Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

NCT06426836 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-01-16

No results posted yet for this study

Summary

Pharmacokinetics of antibiotics in critically ill neonates, infants and children on extracorporeal membrane oxygenation (ECMO).

Conditions

  • Pharmacokinetics
  • Amoxicillin-clavulanate
  • Piperacillin-tazobactam
  • Meropenem
  • Cefazolin
  • Teicoplanin
  • Vancomycin
  • Ciprofloxacin
  • Amikacin

Interventions

OTHER

Amoxicillin-clavulanate

blood sampling in patients receiving amoxicillin-clavulanate as part of routine clinical care

OTHER

Piperacillin-tazobactam

blood sampling in patients receiving piperacillin-tazobactam as part of routine clinical care.

OTHER

Meropenem

blood sampling in patients receiving meropenem as part of routine clinical care.

OTHER

Cefazolin

blood sampling in patients receiving cefazolin as part of routine clinical care.

OTHER

Vancomycin

blood sampling in patients receiving vancomycin as part of routine clinical care.

OTHER

Teicoplanin

blood sampling in patients receiving teicoplanin as part of routine clinical care.

OTHER

Ciprofloxacin

blood sampling and urine sampling in patients receiving ciprofloxacin as part of routine clinical care.

OTHER

Amikacin

blood sampling in patients receiving amikacin as part of routine clinical care.

Sponsors & Collaborators

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Annick de Jaeger, MD · University Hospital, Ghent

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-19
Primary Completion
2026-07-01
Completion
2026-07-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06426836 on ClinicalTrials.gov